(VIANEWS) – Shares of NYXOAH (BEL 20: NYXH.BR) rose by a staggering 30.76% in 21 sessions from €6.21 to €8.12 at 02:22 EST on Monday, after two consecutive sessions in a row of losses. BEL 20 is jumping 0.06% to €3,826.30, following the last session’s upward trend.
NYXOAH’s last close was €8.12, 52.57% below its 52-week high of €17.12.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.22%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 26.9% and a negative 78.9%, respectively.
More news about NYXOAH (NYXH.BR).
